Endpoints and cutpoints in head and neck oncology trials: methodical background, challenges, current practice and perspectives

  • Marcus Hezel
  • Kathrin von Usslar
  • Thiemo Kurzweg
  • Balazs B Lörincz
  • Rainald Knecht

Related Research units

Abstract

This article reviews the methodical and statistical basics of designing a trial, with a special focus on the process of defining and choosing endpoints and cutpoints as the foundations of clinical research, and ultimately that of evidence-based medicine. There has been a significant progress in the treatment of head and neck cancer in the past few decades. Currently available treatment options can have a variety of different goals, depending e.g. on tumor stage, among other factors. The outcome of a specific treatment in clinical trials is measured using endpoints. Besides classical endpoints, such as overall survival or organ preservation, other endpoints like quality of life are becoming increasingly important in designing and conducting a trial. The present work is based on electronic research and focuses on the solid methodical and statistical basics of a clinical trial, on the structure of study designs and on the presentation of various endpoints.

Bibliographical data

Original languageEnglish
ISSN0937-4477
DOIs
Publication statusPublished - 04.2016
PubMed 25573834